Hubert MAROTTE
CHU de Saint-Etienne · Centre Hospitalier Universitaire de Saint Etienne
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hubert MAROTTE as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:23 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07355790 · Evaluation of the Comfort Increase Provided by an Additional Foam Pad on a Lumbar Belt and Its Biophysical ImpactCentre Hospitalier Universitaire de Saint Etienne · completed · Low Back Pain, Healthy Volunteer · principal investigator
- N/ANCT06541548 · Comparison of Bone Microarchitecture Analysed by HRpQCT and pQCT in Pathologies With Bone Loss and/or Muscle LossCentre Hospitalier Universitaire de Saint Etienne · recruiting · Osteoporosis Risk, Bone Loss · principal investigator
- N/ANCT04749160 · Smart Marker Annunciating Response to Rheumatologic Treatments SMART²TCentre Hospitalier Universitaire de Saint Etienne · completed · Rheumatoid Arthritis · principal investigator
- Ph4NCT04470453 · Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Biological Drug Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate and a First Biological DrugCentre Hospitalier Universitaire de Saint Etienne · terminated · Rheumatoid Arthritis · principal investigator
- Ph4NCT03445871 · Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable MethotrexateCentre Hospitalier Universitaire de Saint Etienne · completed · Rheumatoid Arthritis · principal investigator
- Ph4NCT03445845 · Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial SpondyloarthritisCentre Hospitalier Universitaire de Saint Etienne · completed · Axial Spondyloarthritis · study director
- N/ANCT02905175 · Rheumatoid Arthritis Patients and Porphyromonas GingivalisCentre Hospitalier Universitaire de Saint Etienne · completed · Rheumatoid Arthritis · principal investigator
- N/ANCT02675218 · Bone MicroArchitecture Abatacept (BMA2)Centre Hospitalier Universitaire de Saint Etienne · terminated · Arthritis, Rheumatoid · principal investigator
- N/ANCT02531061 · Impact of the Persistence of Inflammation at Doppler Ultrasound Level on the Structural Evolution of Erosion in Rheumatoid Arthritis Treated With BiotherapyCentre Hospitalier Universitaire de Saint Etienne · completed · Rheumatoid Arthritis · principal investigator
- N/ANCT02475486 · Role of the ANS Dysregulation in the Persistence of Fatigue in Rheumatoid Arthritis Patients Treated With Anti-TNFCentre Hospitalier Universitaire de Saint Etienne · completed · Rheumatoid Arthritis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:23 UTC. The ranking covers the 200 most relevant of 12 PubMed records, and a shared surname and initials can bring in a namesake. All 12 on PubMed
- Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial.Aliment Pharmacol Ther · 2017109 citationsRCR 5.2
- A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab.Arthritis Res Ther · 200796 citationsRCR 2.6
- Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus.Rheumatology (Oxford) · 200751 citationsRCR 1.6
- Effect of zolpidem on sleep and ventilatory patterns at simulated altitude of 4,000 meters.Am J Respir Crit Care Med · 199640 citationsRCR 1.7
- Early occupational therapy programme increases hand grip strength at 3 months: results from a randomised, blind, controlled study in early rheumatoid arthritis.Ann Rheum Dis · 200933 citationsRCR 1.3
- Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study.Ann Rheum Dis · 202019 citationsRCR 1.2
- 10 citationsRCR 4.1
- Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission.Arthritis Rheumatol · 20246 citationsRCR 1.1
- Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial.Lancet Rheumatol · 20256 citationsRCR 2.2